Dakota Clouse

The people who want opens borders use bulletproof glass now to give speeches 😂

I’m still laughing at the fact first responders had to be called to get this kid unstuck 😂

They are cutting down the forest inside the Adirondack Mountains in upstate New York so they can install solar panels. I’m not sure how anyone could still believe the climate change hoax at this point. It’s a giant money laundering scam. This crap needs to stop ASAP.

Spencer Pratt: “We need to clean up homeless camps, get rid of the drug addicted everywhere, prepare for fires better, and lower taxes.” Nithya Raman: “We need to ban the normals from cooking hamburgers.” The right vs. left paradigm perfectly illustrated.

Pro Tip: You have to fix the meth problem before you fix the teeth problem.

@MikeTbaker13 @BrewerNation 100%, hard to be a rivalry when we only face off with them for 2 series a year, and a lot of those have been 2 game series which is dumb

@BrewerNation I live in on the west side of the state its a fun series not a rivalry.

Fair point.

Good job California, keep fighting the good fight.

🛜 Dr. Brian Hooker and Mary Holland warn 5G is just the beginning, with 6G and 7G on the way. “The effects of microwave radiation … that is how our communication system and society operates now.” “And they’re talking about rolling out 6G and 7G.” “Increased energy intensity that we are subjecting ourselves to.” “There is really no say… in terms of where a cell phone tower is added within your community.” “The telecommunications industry has largely captured our Federal Communications Commission.” @maryhollandnyc @BrianHookerPhD @704nomore @Stop5GNearMe

Janet Mills and @MaineDems are allowing foreigners to run Medicaid scams **out of campers** — How did this pass a site inspection? Who approved this?

Probably the most surreal 'zombie' home health care office we've seen yet. Zahraa Home Care, run out of a trailer, billed MaineCare for $233,392.39 in 2025. After filming this video, we were able to get in touch with the owner (not through the listed phone number on the sign), who told us the business did not have a permit. He also told us they only have one client... But good news. They're hiring!

The U.S. Forest Service is spraying glyphosate (Roundup) across tens of thousands of acres of national forests this spring to support commercial timber production. Following wildfires, forests naturally regenerate with diverse shrubs, wildflowers, and wildlife. However, a recent investigation reveals that the Forest Service and private logging companies are routinely applying the herbicide to eliminate competing native vegetation, favoring commercially valuable species such as Douglas fir and sugar pine. This practice has created large areas with significantly reduced biodiversity, often described as "dead zones", where insect, bird, and plant populations have sharply declined. Glyphosate, classified by the World Health Organization as a probable human carcinogen, has seen its use in California national forests quintuple over the past two decades, reaching a record 266,000 pounds in 2023. Local communities, environmental groups, and residents are raising concerns about potential impacts on water quality, endangered species (including salmon and rare foxes), and public health. Critics argue that prioritizing industrial timber production over ecological diversity conflicts with the broader mission of national forests as public lands. The issue has intensified debates over forest management, balancing economic interests with long-term environmental and community health.

If Gov. Newsom was not running a new $20 million grift through a $77 million "non-profit," the state could just provide coupons for free diapers to new mothers. But then taxpayer money couldn't be disappeared into a non-profit.

The woman who runs Baby2Baby - the NGO that will be funded by state money to deliver on this promise - sits on the board of Gavin Newsom’s wife’s company. This is just graft hidden in plain sight.

Ok… most of you know I was in the organic baby formula business, but what you don’t know is I dabbled in diapers as well. I also know this baby2baby “non profit” and have had past interactions with them.. I’ll leave that out for now.. Let’s dive into this absolute grifting nonsense. Prepare to be shocked. California is about to spend $20 million of taxpayer money to give 100,000 newborns 400 diapers each through Baby2Baby. Do the math with me: 100,000 babies × 400 diapers = 40 million diapers $20,000,000 ÷ 40,000,000 = $0.50 per diaper!!!!! Now walk into any Costco in California and you can buy the same quality diapers for .12 to .15 cents each! That’s $48 to $60 for 400 diapers. So the state is paying 8–10x more per diaper than a regular family buying in bulk. They could’ve just handed every low-income new mom $100 cash and told her to go to Costco. She’d get more diapers, better ones if she wanted, and still have money left for formula, wipes, or whatever the hell she actually needs. But nah… that wouldn’t let Gavin and his connected “nonprofit” girls running the show there cut ribbons, take photos, do galas and be friends with celebrities and brag about the “first-in-the-nation” program while skimming their cut for “administration” and “partnerships.” This is peak government stupidity!!! Spend way more money to feel good and look good, instead of just trusting parents with their own damn money. We’re not helping babies. We’re funding another bloated nonprofit-government grift. Math doesn’t lie. The diaper math is brutal. What a scam and a joke!!!!!

$CLOV Q1 2026 earnings: The Flywheel Engages: Massive Top-Line Surge and a Swing to Profitability Clover Health's Q1 2026 results confirm management's multi-year narrative: the 'growth flywheel' has been activated. Fueled by a lucrative transition to a 4-Star payment year and aggressive prior-year member acquisition, total revenues accelerated by 62% YoY to $749.2M. More importantly, the company posted its highest GAAP Net Income to date at $27.3M, a dramatic reversing of historical losses. While the top-line execution and operating leverage are undeniably impressive, a glaring contradiction in guidance requires investor caution: the company expects FY26 GAAP Net Income of $0-$20M, implying that Q2-Q4 will operate at a net loss. Full article with charts - link in bio 🐂 𝐁𝐮𝐥𝐥 𝐂𝐚𝐬𝐞 • 𝐔𝐧𝐩𝐫𝐞𝐜𝐞𝐝𝐞𝐧𝐭𝐞𝐝 𝐆𝐫𝐨𝐰𝐭𝐡 𝐚𝐭 𝐒𝐜𝐚𝐥𝐞 — Membership grew 51% YoY to over 155,000, and revenue growth accelerated to 62% YoY. Clover is aggressively taking market share in the PPO space as competitors retreat. • 𝐏𝐫𝐨𝐟𝐢𝐭𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐈𝐧𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐑𝐞𝐚𝐜𝐡𝐞𝐝 — The long-awaited 4-Star payment tailwind and the maturation of the 2025 member cohort have successfully flipped the company to GAAP profitability, yielding $27.3M in Q1. 🐻 𝐁𝐞𝐚𝐫 𝐂𝐚𝐬𝐞 • 𝐓𝐡𝐞 𝐐𝟐-𝐐𝟒 𝐒𝐢𝐧𝐤𝐡𝐨𝐥𝐞 — With Q1 Net Income at $27.3M and FY26 guided to $0-$20M, the company implies it will lose between $7.3M and $27.3M over the next three quarters. The profit narrative is highly front-loaded. • 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐂𝐨𝐬𝐭𝐬 𝐂𝐫𝐞𝐞𝐩𝐢𝐧𝐠 𝐔𝐩 — The Insurance Benefits Expense Ratio (BER) ticked up 40 bps YoY to 86.5%. Despite the massive 4-Star revenue boost, medical costs continue to consume a slightly larger portion of premiums. ⚖️ 𝐕𝐞𝐫𝐝𝐢𝐜𝐭: 🟢 Bullish. The sheer velocity of revenue and membership growth, coupled with a swing to GAAP profitability, outweighs near-term seasonality concerns. Clover has proven its technology-first model can scale profitably. 𝐊𝐞𝐲 𝐓𝐡𝐞𝐦𝐞𝐬 🟢🟢 𝐓𝐡𝐞 𝟒-𝐒𝐭𝐚𝐫 𝐏𝐚𝐲𝐦𝐞𝐧𝐭 𝐂𝐚𝐭𝐚𝐥𝐲𝐬𝐭 𝐈𝐠𝐧𝐢𝐭𝐞𝐬 [NEW] The transition from a 3.5-Star to a 4-Star payment year in 2026 is delivering exactly as management projected in 2025. This structural benchmark advantage allows Clover to offer highly competitive PPO benefits while simultaneously expanding margins. Total revenue growth is sharply accelerating, hitting 62% in Q1 compared to 30-40% levels seen throughout 2025. 🟢 𝐂𝐨𝐡𝐨𝐫𝐭 𝐌𝐚𝐭𝐮𝐫𝐚𝐭𝐢𝐨𝐧 𝐘𝐢𝐞𝐥𝐝𝐬 𝐑𝐞𝐭𝐮𝐫𝐧𝐬 During 2025, management absorbed significant margin pressure (guiding down adjusted EBITDA) to fund a massive influx of new members, claiming they would become profitable in year two. Q1 2026 data validates this claim. The gross profit surge of 46.5% YoY proves that the initial drag of the 2025 cohort has successfully transitioned into a profitable returning member base. 🟢 𝐒𝐆&𝐀 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐋𝐞𝐯𝐞𝐫𝐚𝐠𝐞 𝐑𝐞𝐚𝐥𝐢𝐳𝐞𝐝 As the top-line explodes, Clover is keeping a tight lid on corporate overhead. Adjusted SG&A as a percentage of total revenues dropped 210 basis points YoY to 15.9%. This operational efficiency was the secondary mechanism necessary to swing Adjusted EBITDA up 56% to $40.3M. 🔴 𝐓𝐡𝐞 𝐐𝟏 𝐏𝐫𝐨𝐟𝐢𝐭 𝐂𝐨𝐧𝐭𝐫𝐚𝐝𝐢𝐜𝐭𝐢𝐨𝐧 [NEW] A massive red flag sits in the guidance math. Management celebrates Q1 GAAP Net Income of $27.3M, yet guides for a full-year GAAP Net Income of $0 to $20M. This explicitly implies that Q2, Q3, and Q4 will generate a combined net loss. While some seasonality in healthcare utilization is normal, a potential $27M reversal in the back nine months suggests that management anticipates severe medical cost headwinds, or they are heavily sandbagging guidance. ⚪ 𝐈𝐧𝐬𝐮𝐫𝐚𝐧𝐜𝐞 𝐁𝐄𝐑 𝐓𝐢𝐜𝐤𝐢𝐧𝐠 𝐇𝐢𝐠𝐡𝐞𝐫 Despite the structural revenue advantage of a 4-Star year, the Insurance Benefits Expense Ratio (BER) expanded 40 bps to 86.5%. While this remains within a stable operating band, it confirms that underlying systemic utilization pressures (such as Part D and supplemental benefits cited heavily in 2025) are persistently challenging to offset. ⚪ 𝐂𝐨𝐮𝐧𝐭𝐞𝐫𝐩𝐚𝐫𝐭 𝐇𝐞𝐚𝐥𝐭𝐡 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥 𝐎𝐛𝐬𝐜𝐮𝐫𝐢𝐭𝐲 Management continues to pitch its 'Counterpart Assistant' SaaS offering as a massive blue-ocean opportunity to monetize its AI infrastructure with external payors. However, the Q1 2026 materials offer zero quantitative metrics—no ARR, no partner count, and no distinct segment breakout. Until the data arrives, this remains an unproven narrative. ⚪ 𝐌𝐚𝐜𝐫𝐨: 𝐏𝐞𝐫𝐬𝐢𝐬𝐭𝐞𝐧𝐭 𝐈𝐧𝐟𝐥𝐚𝐭𝐢𝐨𝐧 & 𝐈𝐑𝐀 𝐂𝐨𝐦𝐩𝐥𝐞𝐱𝐢𝐭𝐢𝐞𝐬 The company's forward-looking statements specifically call out 'persistent high inflation' and ongoing shifts in Medicare Advantage regulations. Given the lack of clarity on how the second year of the Part D IRA redesign will hit the industry, this macro backdrop helps explain management's highly conservative back-half profit guidance. 🟢 𝐂𝐥𝐨𝐯𝐞𝐫 𝐀𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐭: 𝐓𝐡𝐞 𝐂𝐨𝐫𝐞 𝐓𝐞𝐜𝐡 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭𝐢𝐚𝐭𝐨𝐫 The fundamental engine of Clover's model—Clover Assistant—continues to prove its worth. Management attributes earlier disease identification, better chronic care management, and their market-leading PPO HEDIS scores entirely to this proprietary software platform. 𝐎𝐭𝐡𝐞𝐫 𝐊𝐏𝐈𝐬 𝐀𝐝𝐣𝐮𝐬𝐭𝐞𝐝 𝐄𝐁𝐈𝐓𝐃𝐀 (𝟐𝟔𝐐𝟏): $40.3 million Accelerating. Up 56.2% year-over-year. A clear indication that core operations are scaling profitably after the heavy investments made in 2025. 𝐓𝐨𝐭𝐚𝐥 𝐂𝐚𝐬𝐡, 𝐄𝐪𝐮𝐢𝐯𝐚𝐥𝐞𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬: $418.2 million Stable. Up 7.0% from Q1 2025 ($390.8M). The company is successfully self-funding its hyper-growth without deteriorating its balance sheet. 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞 𝐅𝐘𝟐𝟔 𝐓𝐨𝐭𝐚𝐥 𝐑𝐞𝐯𝐞𝐧𝐮𝐞𝐬: $2.81 - $2.92 billion Accelerating. The midpoint of $2.865B represents ~49% growth year-over-year compared to the ~$1.865B expected for FY25, highlighting the immense top-line impact of the 4-Star rating and continued market share capture. 𝐅𝐘𝟐𝟔 𝐀𝐯𝐞𝐫𝐚𝐠𝐞 𝐌𝐀 𝐌𝐞𝐦𝐛𝐞𝐫𝐬𝐡𝐢𝐩: 154,000 - 158,000 Accelerating. Midpoint represents 46% year-over-year growth, up from the ~33% growth rate seen throughout 2025. Clover is aggressively capitalizing on competitor pullbacks. 𝐅𝐘𝟐𝟔 𝐀𝐝𝐣𝐮𝐬𝐭𝐞𝐝 𝐄𝐁𝐈𝐓𝐃𝐀: $50 - $70 million Reversing. A significant leap compared to the heavily suppressed $15M-$30M guidance exiting 2025, driven by cohort maturation and 4-Star rates. 𝐅𝐘𝟐𝟔 𝐆𝐀𝐀𝐏 𝐍𝐞𝐭 𝐈𝐧𝐜𝐨𝐦𝐞: $0 - $20 million Reversing. Expected to be the first full year of GAAP profitability in company history. However, given Q1 delivered $27.3M, this guidance implies a dramatic deceleration and net losses for the remainder of the year. 𝐊𝐞𝐲 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐓𝐡𝐞 𝐈𝐦𝐩𝐥𝐢𝐞𝐝 𝐐𝟐-𝐐𝟒 𝐋𝐨𝐬𝐬 With $27.3 million in Q1 GAAP Net Income, your full-year guidance of $0 to $20 million mathematically requires a net loss for the rest of the year. Is this purely conservative sandbagging, or do you expect specific, severe medical cost headwinds to materialize? 𝐂𝐨𝐮𝐧𝐭𝐞𝐫𝐩𝐚𝐫𝐭 𝐇𝐞𝐚𝐥𝐭𝐡 𝐌𝐨𝐧𝐞𝐭𝐢𝐳𝐚𝐭𝐢𝐨𝐧 You've highlighted Counterpart Health as a massive growth vector. When will investors see specific KPIs like ARR, active partner counts, or a dedicated segment revenue breakout? 𝐁𝐄𝐑 𝐌𝐚𝐫𝐠𝐢𝐧 𝐄𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 Despite a massive step-up in revenue from the 4-Star payment transition, the Insurance BER still ticked up by 40 basis points. What is driving the inability to leverage this higher premium revenue into a lower medical loss ratio? 𝐏𝐚𝐫𝐭 𝐃 𝐚𝐧𝐝 𝐈𝐑𝐀 𝐈𝐦𝐩𝐚𝐜𝐭 In 2025, the industry was caught off guard by Part D utilization related to IRA changes. How is the 2026 plan design and current utilization data insulating Clover from a repeat scenario?

850 million children, or ONE THIRD of genZ, were murdered by their own mothers that’s about 10 times as many deaths as during World War II

🚨 OH. MY. GOSH!!!!!!! It has been revealed that the city of Asheville NC will only rebuild 8 HOUSES with the $225 MILLION grant they received from the Trump administration after Hurricane Helene. Yes, you read that right... EIGHT!!!!!!!!!!! ...OUT OF 11,488 DAMAGED HOMES The city allocated ONLY $3 MILLION for home repairs. And $14.9 MILLION for "administration" FIVE TIMES MORE for PAPERWORK than for the people whose homes got COMPLETELY DESTROYED!!!!!! Over 100+ approved families are CURRENTLY ON A WAITLIST that will never be funded. THIS IS CRIMINAL!!!!!!!!!!! PEOPLE NEED TO GO TO JAIL!!!!!!!!!!!!

EXCLUSIVE: Wisconsin Attorney General Josh Kaul's mandatory DEI program includes curriculum by a self-described “non-binary mystic and pleasure activist” who sells $600-an-hour "solo time travel sessions." heartlandpost.com/exclusive-kaul…

$CLOV UBS analyst: "Clover Health is worth $2.75." UBS bank: quietly buys 1.77 million shares of Clover Health. Read that again. Their analyst Jonathan Yong has cut the price target 3 times in 7 months, from $4.50 to $2.75. Down 39%. While he was doing that, UBS Group AG grew its position from 32,546 shares to 1,767,799. A 54x position built right through every downgrade. They tell you to sell so they can buy.